Crossmark

Optimal sequencing of brain radiotherapy and immunotherapy for patients with non-small cell lung cancer and driver gene-negative, asymptomatic brain metastases

Crossref DOI link: https://doi.org/10.1186/s12885-026-15706-y

Published Online: 2026-02-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhong, Wenjuan

Wu, Shugui

Zhu, Rui

Shi, Huaqiu

Yu, Wei

Liu, Linfang

Wu, Longqiu
Funding

Funding for this research was provided by:

The Guiding Science and Technology Programme of Ganzhou City, China (No.GZ2023ZSF160)
License Information

Text and Data Mining valid from 2026-02-15

Version of Record valid from 2026-03-24
More Information

Article History

Received: 25 October 2025

Accepted: 4 February 2026

First Online: 15 February 2026

Declarations

:

: The study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments. This research was approved by the Ethics Committees of the First Affiliated Hospital of Gannan Medical University (No: LLSL-2024 No. 232) and individual consent for this retrospective analysis was waived.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below